Oxidative Medicine and Cellular Longevity / 2011 / Article / Tab 3

Research Article

Evaluation of Chromosomal Instability in Diabetic Rats Treated with Naringin

Table 3

Frequency of spermatocyte chromosomal aberrations in testes of nondiabetic and diabetic rats 24 hours after the last treatment with the indicated doses of naringin (4 weeks exposures, spaced 24 hours apart) (mean ± SD).

Treatment groups (mg/kg)Different structural chromosomal aberrations screenedTotal chromosomal aberrations (%)
X-Y univalentsAutosomal univalentsF/BPolyploidyMV

Nondiabetic control742012.8 ± 0.44
Nondiabetic + naringin (25)63112.4 ± 0.89
Nondiabetic + naringin (50)561012.6 ± 0.89
Diabetes22183239.60 ± 1.51*
Diabetes + naringin (25)13102115.40 ± 1.81a
Diabetes + naringin (50)652213.20 ± 1.09b

, versus nondiabetic control (Kruskal-Wallis test followed by Dunn’s multiple comparisons test). a and b versus diabetes alone (Mann-Whitney U test). F: fragments; B: breaks; MV: multivalents having a chain of four chromosomes.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.